In a rat model of FM induced by reserpine, treatment with honokiol reduced pain, depression and anxiety, increased SOD and IL-10 levels, and decreased MDA, TNF-α and prostaglandin E2 (PGE2) levels. This evidence concerns the gene TNF and depressive symptom measurement.